Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-28 · accession 0001870913-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-08-30 | 2023-08-28+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $63.22 | -50.0K | 1.13M | -4% | -$3.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | S | D | 25,000 | $63.06 | 1,157,620 | I Held by Esjay LLC | — | — | (F1) Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| 2 | Common | Common Stock | 2023-08-29 | S | D | 25,000 | $63.37 | 1,132,620 | I Held by Esjay LLC | — | — | (F3) Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive. (F2) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |